What is the current annual EBITDA of ILMN?

As of today, ILMN annual EBITDA is $1.25B

What is 1-year change in ILMN annual EBITDA?

ILMN annual EBITDA is up +66.18% year-over-year

What is 3-year change in ILMN annual EBITDA?

ILMN annual EBITDA is up +67.51% over the past 3 years

How far is ILMN annual EBITDA from its all-time high?

ILMN annual EBITDA is currently at its all-time high

How does ILMN annual EBITDA rank versus sector peers?

ILMN annual EBITDA is higher than 93.79% of companies in Healthcare sector

When is ILMN next annual earnings release?

The next annual earnings release for ILMN is on February 4, 2027

What is the current quarterly EBITDA of ILMN?

As of today, ILMN quarterly EBITDA is $351.00M

What is ILMN quarterly EBITDA most recent change?

ILMN quarterly EBITDA was up +24.91% on September 27, 2026

What is 1-year change in ILMN quarterly EBITDA?

ILMN quarterly EBITDA is up +17.79% year-over-year

How far is ILMN quarterly EBITDA from its all-time high?

ILMN quarterly EBITDA is currently -43.20% below its historical high of $618.00M set on September 29, 2024

How does ILMN quarterly EBITDA rank versus sector peers?

ILMN quarterly EBITDA is higher than 93.04% of companies in Healthcare sector

When is ILMN next earnings release?

The next earnings release for ILMN is on February 4, 2027

What is the current TTM EBITDA of ILMN?

As of today, ILMN TTM EBITDA is $1.22B

What is ILMN TTM EBITDA most recent change?

ILMN TTM EBITDA was up +4.55% on September 27, 2026

What is 1-year change in ILMN TTM EBITDA?

ILMN TTM EBITDA is up +9.43% year-over-year

How far is ILMN TTM EBITDA from its all-time high?

ILMN TTM EBITDA is currently -29.66% below its historical high of $1.73B set on March 30, 2025

How does ILMN TTM EBITDA rank versus sector peers?

ILMN TTM EBITDA is higher than 93.24% of companies in Healthcare sector

When is ILMN next earnings release?

The next earnings release for ILMN is on February 4, 2027

Illumina, Inc. (ILMN) EBITDA History & Chart Since 1998

Annual EBITDA

$1.25B$499.00M+66.18%

December 31, 2025

Summary

Current Value: As of today, ILMN annual EBITDA is $1.25B, up +66.18% on December 31, 2025
Historical Performance: ILMN annual EBITDA is up +67.51% over the past 3 years, up +63.36% over the past 5 years
All-Time High Comparison: ILMN annual EBITDA is currently at its all-time high
3-Year Low Comparison: ILMN annual EBITDA is +270.71% above its 3-year low of $338.00M reached on December 31, 2023
Sector Comparison: ILMN annual EBITDA is higher than 93.79% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ILMN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.25B	+66.2%	+67.5%	+63.4%	+412.2%
Quarterly EBITDA	Sep 27, 26	$351.00M	+17.8%	+101.7%	+173.1%	+499.7%
TTM EBITDA	Sep 27, 26	$1.22B	+9.4%	+263.9%	+584.8%	+292.4%
Price	Nov 12, 26	$210.14	+72.3%	+119.6%	-43.7%	+579.5%
PE Ratio	Nov 12, 26	36.10	+32.1%	–	-41.2%	-8.9%
Annual Revenue	Dec 31, 25	$4.34B	-0.4%	-5.4%	+33.9%	+380.5%
Annual EPS	Dec 31, 25	$5.45	+170.8%	+119.4%	+22.9%	+526.3%
	Dec 31, 25	$983.00M	+145.8%	+177.7%	+69.5%	+385.2%
Annual Net Income	Dec 31, 25	$850.00M	+169.5%	+119.3%	+29.6%	+580.6%

EBITDA Highs

ILMN Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.25B	Dec 31, 25	at high
5Y	$1.25B	Dec 31, 25	at high
All	$1.25B	Dec 31, 25	at high

EBITDA Lows

ILMN Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$338.00M	Dec 31, 23	+270.7%
5Y	$338.00M	Dec 31, 23	+270.7%
All	-$29.27M	Dec 29, 02	+4380.5%

EBITDA History

Year	Value	Change
2025	$1.25B	+66.2%
2024	$754.00M	+123.1%
2023	$338.00M	-54.8%
2022	$748.00M	+39.3%
2021	$537.00M	-30.0%
2020	$767.00M	-35.1%
2019	$1.18B	+11.2%
2018	$1.06B	+35.5%
2017	$784.00M	+8.3%
2016	$724.08M	-3.4%
2015	$749.53M	+25.2%
2014	$598.61M	+46.3%
2013	$409.14M	+24.2%
2012	$329.45M	+2.2%

Year	Value	Change
2011	$322.36M	+31.8%
2010	$244.61M	+45.5%
2009	$168.11M	+22.8%
2008	$136.91M	+93.8%
2007	$70.63M	+60.9%
2006	$43.90M	+2,967.1%
2005	-$1.53M	+73.4%
2004	-$5.76M	+73.0%
2003	-$21.32M	+27.2%
2002	-$29.27M	-1.5%
2001	-$28.85M	-36.3%
2000	-$21.17M	-260.3%
1999	-$5.88M	-392.0%
1998	-$1.19M	-

FAQ

What is the current annual EBITDA of ILMN?: As of today, ILMN annual EBITDA is $1.25B
What is 1-year change in ILMN annual EBITDA?: ILMN annual EBITDA is up +66.18% year-over-year
What is 3-year change in ILMN annual EBITDA?: ILMN annual EBITDA is up +67.51% over the past 3 years
How far is ILMN annual EBITDA from its all-time high?: ILMN annual EBITDA is currently at its all-time high
How does ILMN annual EBITDA rank versus sector peers?: ILMN annual EBITDA is higher than 93.79% of companies in Healthcare sector
When is ILMN next annual earnings release?: The next annual earnings release for ILMN is on February 4, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$351.00M$70.00M+24.91%

September 27, 2026

Summary

Current Value: As of today, ILMN quarterly EBITDA is $351.00M, up +24.91% on September 27, 2026
Historical Performance: ILMN quarterly EBITDA is up +17.79% year-over-year, up +101.72% over the past 3 years
All-Time High Comparison: ILMN quarterly EBITDA is currently -43.20% below its historical high of $618.00M set on September 29, 2024
3-Year Low Comparison: ILMN quarterly EBITDA is +616.33% above its 3-year low of $49.00M reached on March 31, 2024
Sector Comparison: ILMN quarterly EBITDA is higher than 93.04% of companies in Healthcare sector

Performance

ILMN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 27, 26	$351.00M	+24.9%	+17.8%	+101.7%	+173.1%
Annual EBITDA	Dec 31, 25	$1.25B	–	+66.2%	+67.5%	+63.4%
TTM EBITDA	Sep 27, 26	$1.22B	+4.5%	+9.4%	+263.9%	+584.8%
Price	Nov 12, 26	$210.14	+8.9%	+72.3%	+119.6%	-43.7%
PE Ratio	Nov 12, 26	36.10	+0.4%	+32.1%	–	-41.2%
Quarterly Revenue	Sep 27, 26	$1.13B	-2.7%	+4.3%	+1.0%	+2.0%
Quarterly EPS	Sep 27, 26	$1.43	+5.6%	+46.7%	+129.9%	-31.1%
	Sep 27, 26	$279.00M	+32.2%	+20.8%	+322.7%	+151.2%
Quarterly Net Income	Sep 27, 26	$220.00M	+6.3%	+46.7%	+129.2%	-30.6%

Quarterly EBITDA Highs

ILMN Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$351.00M	Sep 27, 26	at high
3Y	$618.00M	Sep 29, 24	-43.2%
5Y	$618.00M	Sep 29, 24	-43.2%
All	$618.00M	Sep 29, 24	-43.2%

Quarterly EBITDA Lows

ILMN Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$263.00M	Mar 29, 26	+33.5%
3Y	$49.00M	Mar 31, 24	+616.3%
5Y	-$480.00M	N/A	+173.1%
All	-$480.00M	Sep 1, 21	+173.1%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$351.00M	+24.9%
Jun 2026	$281.00M	+6.8%
Mar 2026	$263.00M	-18.8%
Dec 2025	$324.00M	+8.7%
Sep 2025	$298.00M	+2.8%
Jun 2025	$290.00M	+14.6%
Mar 2025	$253.00M	-7.3%
Dec 2024	$273.00M	-55.8%
Sep 2024	$618.00M	+4.9%
Jun 2024	$589.00M	+1,102.0%
Mar 2024	$49.00M	-54.6%
Dec 2023	$108.00M	-37.9%
Sep 2023	$174.00M	+443.8%
Jun 2023	$32.00M	-25.6%
Mar 2023	$43.00M	-50.0%
Dec 2022	$86.00M	-75.4%
Sep 2022	$349.00M	+181.5%
Jun 2022	$124.00M	-54.9%
Mar 2022	$275.00M	+80.9%
Dec 2021	$152.00M	+131.7%
Sep 2021	-$480.00M	-303.4%
Jun 2021	$236.00M	-2.1%
Mar 2021	$241.00M	+33.1%
Dec 2020	$181.00M	-13.4%
Sep 2020	$209.00M	+47.2%
Jun 2020	$142.00M	-39.1%
Mar 2020	$233.00M	-25.6%
Dec 2019	$313.00M	-11.8%
Sep 2019	$355.00M	+39.8%
Jun 2019	$254.00M	+1.2%
Mar 2019	$251.00M	+1.6%
Dec 2018	$247.00M	-13.6%
Sep 2018	$286.00M	+5.1%
Jun 2018	$272.00M	+5.8%
Mar 2018	$257.00M	-4.1%
Dec 2017	$268.00M	+20.7%
Sep 2017	$222.00M	+28.3%
Jun 2017	$173.00M	+43.0%
Mar 2017	$121.00M	-33.1%
Dec 2016	$180.83M	-8.2%
Sep 2016	$197.00M	+6.5%
Jun 2016	$185.03M	+17.8%
Mar 2016	$157.05M	-13.5%
Dec 2015	$181.52M	-1.6%
Sep 2015	$184.52M	-1.0%
Jun 2015	$186.44M	-5.4%
Mar 2015	$197.04M	+14.0%
Dec 2014	$172.85M	+7.2%
Sep 2014	$161.26M	+18.7%
Jun 2014	$135.83M	+5.5%
Mar 2014	$128.72M	+17.6%
Dec 2013	$109.42M	+7.1%
Sep 2013	$102.19M	+2.4%
Jun 2013	$99.81M	+2.1%

Month	Value	Change
Mar 2013	$97.72M	+14.8%
Dec 2012	$85.13M	-4.7%
Sep 2012	$89.35M	+31.0%
Jun 2012	$68.19M	-17.3%
Mar 2012	$82.45M	-1.6%
Dec 2011	$83.79M	+43.2%
Sep 2011	$58.53M	-36.3%
Jun 2011	$91.82M	+1.9%
Mar 2011	$90.15M	+28.5%
Dec 2010	$70.18M	+2.5%
Sep 2010	$68.44M	+16.5%
Jun 2010	$58.76M	+24.4%
Mar 2010	$47.24M	+8.3%
Dec 2009	$43.60M	+12.3%
Sep 2009	$38.84M	-11.5%
Jun 2009	$43.88M	+5.0%
Mar 2009	$41.78M	-4.6%
Dec 2008	$43.81M	+51.6%
Sep 2008	$28.90M	-16.4%
Jun 2008	$34.56M	+37.3%
Mar 2008	$25.17M	-2.0%
Dec 2007	$25.69M	+34.3%
Sep 2007	$19.13M	+21.3%
Jun 2007	$15.77M	+57.0%
Mar 2007	$10.05M	-45.5%
Dec 2006	$18.44M	+9.0%
Sep 2006	$16.91M	+111.9%
Jun 2006	$7.98M	+1,327.9%
Mar 2006	$559.00K	-62.8%
Dec 2005	$1.50M	+360.0%
Sep 2005	-$578.00K	+69.4%
Jun 2005	-$1.89M	-232.4%
Mar 2005	-$568.00K	-200.4%
Dec 2004	$566.00K	+126.7%
Sep 2004	-$2.12M	-3.3%
Jun 2004	-$2.05M	+5.1%
Mar 2004	-$2.16M	+21.1%
Dec 2003	-$2.74M	+31.9%
Sep 2003	-$4.02M	+43.8%
Jun 2003	-$7.14M	+7.1%
Mar 2003	-$7.69M	-17.2%
Dec 2002	-$6.57M	+1.6%
Sep 2002	-$6.67M	+16.2%
Jun 2002	-$7.96M	+1.3%
Mar 2002	-$8.07M	-5.4%
Dec 2001	-$7.65M	-11.0%
Sep 2001	-$6.90M	+2.7%
Jun 2001	-$7.09M	-9.0%
Mar 2001	-$6.50M	+20.6%
Dec 2000	-$8.19M	-56.9%
Sep 2000	-$5.22M	+7.7%
Jun 2000	-$5.65M	+18.4%
Mar 2000	-$6.93M	-

FAQ

What is the current quarterly EBITDA of ILMN?: As of today, ILMN quarterly EBITDA is $351.00M
What is ILMN quarterly EBITDA most recent change?: ILMN quarterly EBITDA was up +24.91% on September 27, 2026
What is 1-year change in ILMN quarterly EBITDA?: ILMN quarterly EBITDA is up +17.79% year-over-year
How far is ILMN quarterly EBITDA from its all-time high?: ILMN quarterly EBITDA is currently -43.20% below its historical high of $618.00M set on September 29, 2024
How does ILMN quarterly EBITDA rank versus sector peers?: ILMN quarterly EBITDA is higher than 93.04% of companies in Healthcare sector
When is ILMN next earnings release?: The next earnings release for ILMN is on February 4, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.22B$53.00M+4.55%

September 27, 2026

Summary

Current Value: As of today, ILMN TTM EBITDA is $1.22B, up +4.55% on September 27, 2026
Historical Performance: ILMN TTM EBITDA is up +9.43% year-over-year, up +263.88% over the past 3 years
All-Time High Comparison: ILMN TTM EBITDA is currently -29.66% below its historical high of $1.73B set on March 30, 2025
3-Year Low Comparison: ILMN TTM EBITDA is +263.88% above its 3-year low of $335.00M reached on an earlier date
Sector Comparison: ILMN TTM EBITDA is higher than 93.24% of companies in Healthcare sector

Performance

ILMN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 27, 26	$1.22B	+4.5%	+9.4%	+263.9%	+584.8%
Annual EBITDA	Dec 31, 25	$1.25B	–	+66.2%	+67.5%	+63.4%
Quarterly EBITDA	Sep 27, 26	$351.00M	+24.9%	+17.8%	+101.7%	+173.1%
Price	Nov 12, 26	$210.14	+8.9%	+72.3%	+119.6%	-43.7%
PE Ratio	Nov 12, 26	36.10	+0.4%	+32.1%	–	-41.2%
TTM Revenue	Sep 27, 26	$4.54B	+1.1%	+6.0%	+1.7%	+6.1%
TTM EPS	Sep 27, 26	$5.82	+8.5%	+30.4%	+181.7%	-4.3%
	Sep 27, 26	$941.00M	+5.4%	+12.2%	+1111.8%	+2951.5%
TTM Net Income	Sep 27, 26	$895.00M	+8.5%	+27.3%	+179.6%	-1.2%

TTM EBITDA Highs

ILMN TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.22B	Sep 27, 26	at high
3Y	$1.73B	Mar 30, 25	-29.7%
5Y	$1.73B	Mar 30, 25	-29.7%
All	$1.73B	Mar 30, 25	-29.7%

TTM EBITDA Lows

ILMN TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.11B	N/A	+9.4%
3Y	$335.00M	N/A	+263.9%
5Y	$71.00M	Jun 1, 22	+1616.9%
All	-$30.59M	Jun 30, 02	+4085.6%

TTM EBITDA History

Month	Value	Change
Sep 2026	$1.22B	+4.5%
Jun 2026	$1.17B	-0.8%
Mar 2026	$1.18B	+0.9%
Dec 2025	$1.17B	+4.6%
Sep 2025	$1.11B	-22.3%
Jun 2025	$1.43B	-17.3%
Mar 2025	$1.73B	+13.3%
Dec 2024	$1.53B	+12.1%
Sep 2024	$1.36B	+48.3%
Jun 2024	$920.00M	+153.4%
Mar 2024	$363.00M	+1.7%
Dec 2023	$357.00M	+6.6%
Sep 2023	$335.00M	-34.3%
Jun 2023	$510.00M	-15.3%
Mar 2023	$602.00M	-27.8%
Dec 2022	$834.00M	-7.3%
Sep 2022	$900.00M	+1,167.6%
Jun 2022	$71.00M	-61.2%
Mar 2022	$183.00M	+22.8%
Dec 2021	$149.00M	-16.3%
Sep 2021	$178.00M	-79.5%
Jun 2021	$867.00M	+12.2%
Mar 2021	$773.00M	+1.0%
Dec 2020	$765.00M	-14.7%
Sep 2020	$897.00M	-14.0%
Jun 2020	$1.04B	-9.7%
Mar 2020	$1.16B	-1.5%
Dec 2019	$1.17B	+6.0%
Sep 2019	$1.11B	+6.6%
Jun 2019	$1.04B	-1.7%
Mar 2019	$1.06B	-0.6%
Dec 2018	$1.06B	-1.9%
Sep 2018	$1.08B	+6.3%
Jun 2018	$1.02B	+10.8%
Mar 2018	$920.00M	+17.3%
Dec 2017	$784.00M	+12.5%
Sep 2017	$696.83M	+3.7%
Jun 2017	$671.83M	-1.8%
Mar 2017	$683.87M	-5.0%
Dec 2016	$719.91M	-0.1%
Sep 2016	$720.60M	+1.8%
Jun 2016	$708.12M	-0.2%
Mar 2016	$709.53M	-5.3%
Dec 2015	$749.53M	+1.2%
Sep 2015	$740.85M	+3.2%
Jun 2015	$717.59M	+7.6%
Mar 2015	$666.97M	+11.4%
Dec 2014	$598.66M	+11.9%
Sep 2014	$535.23M	+12.4%
Jun 2014	$476.16M	+8.2%
Mar 2014	$440.15M	+7.6%
Dec 2013	$409.14M	+6.3%
Sep 2013	$384.84M	+3.5%
Jun 2013	$372.00M	+9.3%

Month	Value	Change
Mar 2013	$340.38M	+4.7%
Dec 2012	$325.11M	+0.4%
Sep 2012	$323.78M	+10.5%
Jun 2012	$292.96M	-7.5%
Mar 2012	$316.59M	-2.4%
Dec 2011	$324.29M	+4.4%
Sep 2011	$310.67M	-3.1%
Jun 2011	$320.58M	+11.5%
Mar 2011	$287.53M	+17.5%
Dec 2010	$244.61M	+12.2%
Sep 2010	$218.04M	+15.7%
Jun 2010	$188.44M	+8.6%
Mar 2010	$173.56M	+3.2%
Dec 2009	$168.11M	-0.1%
Sep 2009	$168.31M	+6.3%
Jun 2009	$158.37M	+6.3%
Mar 2009	$149.05M	+12.5%
Dec 2008	$132.43M	+15.8%
Sep 2008	$114.32M	+9.3%
Jun 2008	$104.54M	+21.9%
Mar 2008	$85.75M	+21.4%
Dec 2007	$70.63M	+11.4%
Sep 2007	$63.38M	+3.6%
Jun 2007	$61.17M	+14.6%
Mar 2007	$53.38M	+21.6%
Dec 2006	$43.90M	+62.8%
Sep 2006	$26.96M	+184.8%
Jun 2006	$9.47M	+2,443.1%
Mar 2006	-$404.00K	+73.6%
Dec 2005	-$1.53M	+38.0%
Sep 2005	-$2.47M	+38.4%
Jun 2005	-$4.01M	+3.9%
Mar 2005	-$4.17M	+27.6%
Dec 2004	-$5.76M	+36.4%
Sep 2004	-$9.06M	+17.3%
Jun 2004	-$10.96M	+31.7%
Mar 2004	-$16.05M	+25.6%
Dec 2003	-$21.59M	+15.1%
Sep 2003	-$25.42M	+9.5%
Jun 2003	-$28.08M	+2.8%
Mar 2003	-$28.90M	+1.3%
Dec 2002	-$29.27M	+3.6%
Sep 2002	-$30.36M	+0.7%
Jun 2002	-$30.59M	-2.9%
Mar 2002	-$29.71M	-5.6%
Dec 2001	-$28.14M	+1.9%
Sep 2001	-$28.68M	-6.2%
Jun 2001	-$27.00M	-5.6%
Mar 2001	-$25.56M	+1.7%
Dec 2000	-$25.99M	-46.0%
Sep 2000	-$17.80M	-41.5%
Jun 2000	-$12.58M	-81.6%
Mar 2000	-$6.93M	-

FAQ

What is the current TTM EBITDA of ILMN?: As of today, ILMN TTM EBITDA is $1.22B
What is ILMN TTM EBITDA most recent change?: ILMN TTM EBITDA was up +4.55% on September 27, 2026
What is 1-year change in ILMN TTM EBITDA?: ILMN TTM EBITDA is up +9.43% year-over-year
How far is ILMN TTM EBITDA from its all-time high?: ILMN TTM EBITDA is currently -29.66% below its historical high of $1.73B set on March 30, 2025
How does ILMN TTM EBITDA rank versus sector peers?: ILMN TTM EBITDA is higher than 93.24% of companies in Healthcare sector
When is ILMN next earnings release?: The next earnings release for ILMN is on February 4, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ILMN Official Website www.illumina.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1110803/000111080326000018/0001110803-26-000018-index.htm
ILMN Profile on Yahoo Finance finance.yahoo.com/quote/ILMN
ILMN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ilmn